← board
PLSH
distress 5/10 · elevated risk$0.130%today-10% from 52w high
panacealife.com40 employeesFounded 2008Greenwood Village, CODrug Manufacturers - Specialty & Generic
Revenue
pre-revenue
Liquidity
$0M
Runway
0.1 yrs
Shares 1y
+17%
Price & events
+156.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+25.5%
1W
+198.8%
1M
+318.3%
3M
+156.1%
6M
+287.3%
1Y
+25.5%
2Y
—
5Y
-72.1%
All
Overview
- Market Cap
- $2.21M
- Volume
- 0
- 52 Week Range
- $0.03 – $0.14
- Total Shares
- 17.65M
- Float Shares
- 12.52M
- % Held by Insiders
- 47.73%
- % Held by Institutions
- 0.00%
- Beta
- 2.63
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 17,645,352 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.